ºÒÀÀ¼º ³¼Ò¾Ï ȯÀÚ¿¡¼ÀÇ Paclitaxel/Ifosfamide Åõ¿©¿¡ ´ëÇÑ Á¦1»ó Àӻ󿬱¸
Phase I Clinical Trial of Paclitaxel Plus Ifosfamide for the Patients with Refractory Ovarian Cancer
¼È£¼®, ÀÌÀç°ü,
¼Ò¼Ó »ó¼¼Á¤º¸
¼È£¼® ( )
°í·Á´ëÇб³
ÀÌÀç°ü ( )
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
KMID : 0360320000320050895
Abstract
Ovary neoplasm; Chemotherapy; Phase I; Paclitaxel; Ifosfamide; Dose limiting toxicity; Maximum tolerated dose;
Å°¿öµå
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸